Lab Information
Todd Lee (MD)
ScientistClinical Research Unit
Department of Medicine (McGill)
Research Profile
https://www.drtoddlee.com/
Keywords
Quality improvement • patient safety • high value healthcare • antibiotic stewardship • polypharmacyResearch Interests
My research focuses on conducting randomized clinical trials designed to improve the treatment of infectious diseases (e.g., C. difficile, COVID-19, S. aureus, Gram-Negative infections) and to innovate in the domains of care of complex hospitalized patients, care of older adults with polypharmacy, and stewardship of healthcare resources (e.g., testing, medications).Team Members
| Name | Position |
|---|
Latest Publications
- Prosty, C., Hanula, R., Levin, Y., Bogoch, I. I., McDonald, E. G. & Lee, T. C. (2022). Revisiting the Evidence Base for Modern Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
- Sohani, Z. N., Butler-Laporte, G., Aw, A., Belga, S., Benedetti, A., Carignan, A., Cheng, M. P., Coburn, B., Costiniuk, C. T., Ezer, N., Gregson, D., Johnson, A., Khwaja, K., Lawandi, A., Leung, V., Lother, S., MacFadden, D., McGuinty, M., Parkes, L., Qureshi, S., Roy, V., Rush, B., Schwartz, I., So, M., Somayaji, R., Tan, D., Trinh, E., Lee, T. C. & McDonald, E. G. (2022). Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial. BMJ open, vol. 12, p. e053039.
- Albuquerque, A. M., Eckert, I., Tramujas, L., Butler-Laporte, G., McDonald, E. G., Brophy, J. M. & Lee, T. C. (2022). Effect of Tocilizumab, Sarilumab, and Baricitinib on Mortality Among Patients Hospitalized for COVID-19 Treated with Corticosteroids: A Systematic Review and Meta-Analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
- Morris, A. M. & Lee, T. C. (2022). Nirmatrelvir for Nonhospitalized Adults with Covid-19. The New England journal of medicine, vol. 387, p. 474-475.
- Williams, J., Gingras, M.-A., Dubé, R., Lee, T. C. & McDonald, E. G. (2022). Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial. CMAJ open, vol. 10, p. E652-E656.
- Ross, S. B., Bortolussi-Courval, É., Hanula, R., Lee, T. C., Goodwin Wilson, M. & McDonald, E. G. (2022). Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications. JAMA network open, vol. 5, p. e2220184.
- Perri, G.-A., Bortolussi-Courval, É., Brinton, C. D., Berall, A., Santiago, A. T., Morcos, M., Lee, T. C. & McDonald, E. G. (2022). MedSafer to Support Deprescribing for Residents of Long-Term Care: a Mixed-Methods Study. Canadian geriatrics journal : CGJ, vol. 25, p. 175-182.
- Bai, A. D., Lo, C. K., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Corpo, O. D., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol. 122, p. 405-411.
- Tong, S. Y. C., Mora, J., Bowen, A. C., Cheng, M. P., Daneman, N., Goodman, A. L., Heriot, G. S., Lee, T. C., Lewis, R. J., Lye, D. C., Mahar, R. K., Marsh, J., McGlothlin, A., McQuilten, Z., Morpeth, S. C., Paterson, D. L., Price, D. J., Roberts, J. A., Robinson, J. O., van Hal, S. J., Walls, G., Webb, S. A., Whiteway, L., Yahav, D., Davis, J. S. & SNAP study group (2022). The Staphylococcus aureus Network Adaptive Platform Trial protocol: New tools for an old foe. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
- Rocheleau, G. L. Y., Lee, T., Mohammed, Y., Goodlett, D., Burns, K., Cheng, M. P., Tran, K., Sweet, D., Marshall, J., Slutsky, A. S., Murthy, S., Singer, J., Patrick, D. M., Du, B., Peng, Z., Lee, T. C., Boyd, J. H., Walley, K. R., Lamontagne, F., Fowler, R., Winston, B. W., Haljan, G., Vinh, D. C., McGeer, A., Maslove, D., Patrigeon, S. P., Mann, P., Donohoe, K., Hernandez, G., Russell, J. A. & for ARBs CORONA I Investigators (2022). Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19. Critical care medicine.
See also
